Demetra Launches Global Spine Division Following Acquisition of OrthoFundamentals LLC
Global medical technology leader Demetra has announced the launch of its new spine-focused division, Demetra Spine, following its strategic acquisition […]
New Disease Mechanism Suspected in Ovarian Cancer Remission Patients, Landmark Study Reveals
A groundbreaking multi-institutional study has uncovered a hidden mechanism potentially responsible for the high recurrence rate in ovarian cancer patients,
Glioblastoma Funding Sees Surge as Nonprofits Drive Renewed Pharma Interest
In a promising turn for brain cancer research, funding for glioblastoma (GBM) has seen a significant uptick, spurred by nonprofit
Lotte Biologics Accelerates Global CDMO Expansion Across North America and Asia
Seoul, South Korea Lotte Biologics is making significant strides in expanding its global presence in the Contract Development and Manufacturing
Medical Imaging Market Is on the Rising in Europe!
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global
Continuous Glucose Monitoring (CGM) Devices Market Trends in Canada
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada
Surgical Sutures Market Trends in U.S.
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! ? ?? An
Azenta and Frenova Partner to Accelerate Genomic Research in Nephrology Through MyReason® Program
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced
Zenara Pharma Receives FDA Approval for First Generic Sertraline Hydrochloride Capsules with 180-Day Marketing Exclusivity
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)
Silexion Reports Breakthrough Preclinical Results, Showing Up to 97% Inhibition in KRAS-Driven Cancer Cells
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data